BioLargo, Inc.
BLGO
$0.16
$0.00-1.82%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -390.42% | -364.86% | -40.22% | 14.18% | 31.45% |
| Total Depreciation and Amortization | 59.22% | 21.74% | 5.99% | 2.75% | -6.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 709.81% | 240.74% | -103.41% | -91.36% | -73.18% |
| Change in Net Operating Assets | 35.11% | -412.05% | -3,604.50% | -1,005.43% | -66.81% |
| Cash from Operations | -158.80% | -567.41% | -1,373.23% | -199.67% | -35.56% |
| Capital Expenditure | 96.28% | 99.43% | 99.11% | 71.23% | -158.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 686.59% | -- | -- | -- | -- |
| Cash from Investing | 133.03% | 127.81% | 106.11% | 64.89% | -175.52% |
| Total Debt Issued | 48.73% | 3,246.15% | 3,246.15% | 2,136.92% | 1,229.23% |
| Total Debt Repaid | 100.00% | -146.51% | -142.86% | -139.39% | 48.15% |
| Issuance of Common Stock | 33.53% | 31.67% | 33.07% | 1.67% | 19.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -100.00% | -101.08% | -- |
| Cash from Financing | 85.24% | 145.66% | 80.75% | -0.26% | -4.74% |
| Foreign Exchange rate Adjustments | -125.53% | 150.72% | 148.75% | 15.38% | 173.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,622.22% | -20.95% | -208.74% | -265.30% | -99.47% |